Gene expression of vitamin D hydroxylase and megalin in the remnant kidney of nephrectomized rats

Kidney International

Volumn 64, Issue 2, 2003, Pages 414-420

  Takemoto, Fumi ^a   Shinki, Toshimasa ^b   Yokoyama, Keitaro ^b   Inokami, Taketoshi ^b   Hara, Shigeko ^b   Yamada, Akira ^b   Kurokawa, Kiyoshi ^b   Uchida, Shunya ^b  

^a TORANOMON HOSPITAL   (Japan)

^b NONE

Author keywords

Messenger RNA; Renal failure; Secondary hyperparathyroidism; Vitamin D metabolites; Vitamin D receptor

Indexed keywords

25 HYDROXYCOLECALCIFEROL 24 HYDROXYLASE; CALCIDIOL 1 MONOOXYGENASE; CREATININE; MEGALIN; MESSENGER RNA; OXYGENASE; PARATHYROID HORMONE; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; GENE EXPRESSION; KIDNEY FAILURE; MALE; METABOLITE; NEPHRECTOMY; NEPHRON; NONHUMAN; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RNA EXTRACTION; VITAMIN D METABOLISM;

EID: 0037765097     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2003.00114.x     Document Type: Article

References (34)

1. LLACH F, BOVER J: Renal osteodystrophy, in Brenner and Rector's The Kidney, 6th ed, edited by BRENNER BM, Philadelphia, WB Saunders Co., 2000, pp 2103-2186
2. 3 in the rat. Metab Bone Dis Relat Res 4:333-336, 1983
3. JUTTMANN JR, BUURMAN CJ, DE KAM E, et al: Serum concentrations of metabolites of vitamin D in patients with chronic renal failure (CRF). Consequences for the treatment with 1-alpha-hydroxy-derivatives. Clin Endocrinol (Oxf) 14:225-236, 1981
4. 2D. Clin Nephrol 15:18-22, 1981
5. HSU CH, PATEL S, YOUNG EW, SIMPSON RU: Production and degradation of calcitriol in renal failure rats. Am J Physiol 253:F1015-F1019, 1987
6. 3-. Cell 96:507-515, 1999
7. KERJASCHKI D, FARQUHAR MG: The pathogenic antigen of Heymann nephritis is a membrane glycoprotein of the renal proximal tubule brush border. Proc Natl Acad Sci USA 79:5557-5581, 1982
8. SAITO A, PIETROMONACO S, LOO AK, FARQUHAR MG: Complete cloning and sequencing of rat gp330/"megalin," a distinctive member of the low density lipoprotein receptor gene family. Proc Natl Acad Sci USA 91:9725-9729, 1994
9. MOESTRUP SK, CHRISTENSEN EI, NIELSEN S, et al: Binding and endocytosis of proteins mediated by epithelial gp330. Ann N Y Acad Sci 737:124-137, 1994
10. TAKAHASHI S, OKADA K, NAGURA Y, et al: Three-quarters nephrectomy in rats as a model of early renal failure. Jpn J Nephrol 33:27-31, 1991
11. 3-1alpha-hydroxylase cDNA. Proc Natl Acad Sci USA 94:12920-12925, 1997
12. 3 24-hydroxylase from rat kidney mitochondria. FEBS Lett 255:405-408, 1989
13. 3 receptor cDNA. Proc Natl Acad Sci USA 85:1005-1009, 1988
14. URENA P, KUBRUSLY M, MANNSTADT M, et al: The renal PTH/PTHrP receptor is down-regulated in rats with chronic renal failure. Kidney Int 45:605-611, 1994
15. MATHIAS RS, NGUYEN HT, ZHANG MY, PORTALE AA: Reduced expression of the renal calcium-sensing receptor in rats with experimental chronic renal insufficiency. J Am Soc Nephrol 9:2067-2074, 1998
16. PATEL S, SIMPSON RU, HSU CH: Effect of vitamin D metabolites on calcitriol metabolism in experimental renal failure. Kidney Int 36:234-239, 1989
17. 2D levels in renal disease. Kidney Int 24:104-109, 1983
18. 3 in early renal failure. Miner Electrolyte Metab 11:182-185, 1985
19. 3 in intact animals. Endocrinology 140:2224-2231, 1999
20. 2-vitamin D levels in humans: Studies in healthy subjects in calcium-stone formers and in patients with primary hyperparathyroidism. J Clin Endocrinol Metab 45:299-306, 1977
21. SHEN FH, BAYLINK DJ, NIELSEN RL, er al: Increased serum 1,25-dihydroxyvitamin D in idiopathic hypercalciuria. J Lab Clin Med 90:955-962, 1977
22. 3 by calcium and phosphate in the rat. Science 190:578-580, 1975
23. TANAKA Y, DELUCA HF: The control of 25-hydroxyvitamin D metabolism by inorganic phosphorus. Arch Biochem Biophys 154:566-574, 1973
24. PATEL SR, KE HQ, HSU CH: Effect of vitamin D metabolites on calcitriol degradative enzymes in renal failure. Kidney Int 45:509-514, 1994
25. KOENIG KG, LINDBERG JS, ZERWEKH JE, et al: Free and total 1,25-dihydroxyvitamin D levels in subjects with renal disease. Kidney Int 41:161-165, 1992
26. HSU CH, PATEL SR, YOUNG EW: Mechanism of decreased calcitriol degradation in renal failure. Am J Physiol 262:F192-F198, 1992
27. AARSKOG D, AKSNES L: Acute response of plasma 1,25-dihydroxy-vitamin D to parathyroid hormone. Lancet 1:362-363, 1980
28. 3 by a mechanism involving adenosine 3′,5′-monophosphate in rats. Endocrinology 118:1583-1589, 1986
29. 3 24-hydroxylase gene. J Biol Chem 269:10545-10550, 1994
30. IIDA K, SHINKI T, YAMAGUCHI A, et al: A possible role of vitamin D receptors in regulating vitamin D activation in the kidney. Proc Natl Acad Sci USA 92:6112-6116, 1995
31. DELUCA HF: The vitamin D story: A collaborative effort of basic science and clinical medicine. FASEB J 2:224-236, 1988
32. ALMOND JR, BALES CW, LOBAUGH B, et al: Regulation of renal 25-hydroxyvitamin D-1-hydroxylase activity in the mouse after uninephrectomy. Endocrinology 124:2118-2121, 1989
33. 3-1alpha-hydroxylase in the human kidney. J Am Soc Nephrol 10:2465-2473, 1999
34. BELL NH: Renal and nonrenal 25-hydroxyvitamin D-1alpha-hydroxylases and their clinical significance. J Bone Miner Res 13: 350-353, 1998